연구성과로 돌아가기
2024 연구자 정보 (817 / 1079)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Choi, Bo Youl (Choi, BY) |
Hanyang Univ, Inst Hlth & Soc, Seoul, South Korea Hanyang Univ, Coll Med, Dept Prevent Med, Seoul, South Korea Univ Washington, Sch Med, Dept Urol, Seattle, WA USA Fred Hutchinson Canc Ctr, Canc Prevent Program, Publ Hlth Sci, Seattle, WA USA |
|
0000-0003-0115-5736 Choi, Bo Youl |
[JCR상위 37.6] Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort Study | ESCI | 37.6 | INFECTIOUS DISEASES | ychoi3@fredhutch.org; | ||
|
Choi, Hee-Jung (Choi, HJ) |
Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition | ESCI | 37.6 | INFECTIOUS DISEASES | heejinmd@korea.ac.kr; | ||
|
Choi, Hong Seok (Choi, HS) |
제1저자 |
Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu, South Korea Kyungpook Natl Univ, Sch Med, Dept Biomed Sci, KNU Convergence Educ Program BK21 4, Taegu, South Korea |
|
0000-0002-2890-0006 Choi, Hong Seok |
[JCR상위 37.6] TAZ is involved in breast cancer cell migration via regulating actin dynamics | SCIE | 37.6 | ONCOLOGY | thkwon@knu.ac.kr; | |
|
Choi, Jong Yong (Choi, JY) |
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 37.6] Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma | SCIE | 37.6 | ONCOLOGY | oj-cumc@daum.net;pssung@catholic.ac.kr; | ||
|
Choi, Jung-Hyun (Choi, JH) |
Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea |
AAA-4835-2022 Choi, Jah |
0000-0002-1725-8468 Jeon, Jaehyun |
[JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition | ESCI | 37.6 | INFECTIOUS DISEASES | heejinmd@korea.ac.kr; | ||
|
Choi, Jungsoon (Choi, J) |
Hanyang Univ, Dept Math, Seoul, South Korea |
L-1944-2016 Choi, Jungsoon |
0000-0001-6815-1006 Choi, Jungsoon |
[JCR상위 37.6] Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort Study | ESCI | 37.6 | INFECTIOUS DISEASES | ychoi3@fredhutch.org; | ||
|
Choi, Keum-Ju (Choi, KJ) |
Daegu Catholic Univ, Coll Med, Dept Internal Med, Daegu, South Korea |
|
|
[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study [JCR상위 79.3] PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC |
SCIE | 37.6 | ONCOLOGY |
fireajh@gmail.com; ejspulm@pusan.ac.kr;fireajh@gmail.com; |
||
|
Choi, Min Joo (Choi, MJ) |
Catholic Kwandong Univ, Int St Marys Hosp, Coll Med, Div Infect Dis, Incheon, South Korea |
|
|
[JCR상위 37.6] COVID-19 Vaccination Recommendations for 2024-2025 in Korea | ESCI | 37.6 | INFECTIOUS DISEASES | wbpark1@snu.ac.kr; | ||
|
Choi, Won Suk (Choi, WS) |
Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis,Ansan Hosp, Ansan, South Korea KU Med VIC K, Vaccine Innovat Ctr, Seoul 02841, South Korea |
V-2730-2017 Choi, Won Suk Choi, Won |
0000-0001-5874-4764 Choi, Won Suk |
[JCR상위 37.6] COVID-19 Vaccination Recommendations for 2024-2025 in Korea [JCR상위 34.6] Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection [JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition [JCR상위 34.6] Real-world effectiveness of influenza vaccine over a decade during the 2011-2021 seasons-Implications of vaccine mismatch [JCR상위 11.6] Overcoming the age-dependent SARS-CoV-2 vaccine response through hybrid immunity: analysis of humoral and cellular immunity with mass cytometry profiling |
ESCI SCIE |
11.6 |
INFECTIOUS DISEASES IMMUNOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL GERIATRICS & GERONTOLOGY;IMMUNOLOGY |
wbpark1@snu.ac.kr; shkimmd@amc.seoul.kr;hwjeong@chungbuk.ac.kr;jaehoon.ko@samsung.com; heejinmd@korea.ac.kr; wjkim@korea.ac.kr; kohjy2000@gmail.com;zigfried@skku.edu;taeyoon@hanyang.ac.kr; |
||
|
Choi, Young Hwa (Choi, YH) |
Ajou Univ, Dept Internal Med, Coll Med, Suwon, South Korea |
|
|
[JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition | ESCI | 37.6 | INFECTIOUS DISEASES | heejinmd@korea.ac.kr; | ||
|
Choi, Yu Jung (Choi, YJ) |
Chosun Univ, Coll Med, Dept Internal Med, Div Infect Dis, Gwangju, South Korea Chonnam Natl Univ, Med Sch, Dept Internal Med, Div Infect Dis, Gwangju, South Korea Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis,Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea KU Med VIC K, Vaccine Innovat Ctr, Seoul 02841, South Korea |
HOF-0843-2023 Choi, Yu Jung |
|
[JCR상위 37.6] Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID [JCR상위 34.6] Real-world effectiveness of influenza vaccine over a decade during the 2011-2021 seasons-Implications of vaccine mismatch |
ESCI SCIE |
34.6 |
INFECTIOUS DISEASES IMMUNOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL |
infection@korea.ac.kr; wjkim@korea.ac.kr; |
||
|
Choo, Eun Ju (Choo, EJ) |
Soonchunhyang Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Bucheon, South Korea Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Div Infect Dis, Bucheon, South Korea |
|
|
[JCR상위 37.6] COVID-19 Vaccination Recommendations for 2024-2025 in Korea [JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition |
ESCI | 37.6 | INFECTIOUS DISEASES |
wbpark1@snu.ac.kr; heejinmd@korea.ac.kr; |
||
|
Chun, Ho Jong (Chun, HJ) |
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea |
|
|
[JCR상위 37.6] Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma | SCIE | 37.6 | ONCOLOGY | oj-cumc@daum.net;pssung@catholic.ac.kr; | ||
|
Comm Adult Immunization (Comm Adult Immunization) |
|
|
[JCR상위 37.6] COVID-19 Vaccination Recommendations for 2024-2025 in Korea | ESCI | 37.6 | INFECTIOUS DISEASES | wbpark1@snu.ac.kr; | |||
|
Eom, Jung Seop (Eom, JS) |
Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Internal Med, Sch Med, 179 Gudeok Ro, Busan 49241, South Korea |
|
|
[JCR상위 37.6] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study [JCR상위 79.3] PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC |
SCIE | 37.6 | ONCOLOGY |
fireajh@gmail.com; ejspulm@pusan.ac.kr;fireajh@gmail.com; |
페이지 이동: